Insights
TrumpRx and Group Insurance: What Employers Should Be Watching
TrumpRx is emerging as an alternative to traditional PBM contracting structures. While it does not replace employer-sponsored group insurance, it may influence pricing pressure, formulary shifts, and contract negotiations. Here’s what employers need to understand and why pharmacy contract visibility still matters.
Direct Primary Care: Can It Work for Your Organization?
Direct Primary Care offers employers an alternative approach to primary care by prioritizing access, prevention, and predictable costs. This article explores how the DPC model works, where it fits within a broader benefits strategy, and key considerations for organizations evaluating new care delivery options.
The Hidden Savings in Specialty Drug Case Management
Specialty drugs drive a disproportionate share of pharmacy spend, but the biggest savings are often hidden. Learn how specialty drug case management reduces waste, improves outcomes, and lowers total plan costs.
Keeping Up with RxDC and Other Compliance Mandates in 2026
RxDC reporting is just one of several compliance mandates employers must track in 2026. This article outlines what RxDC requires, why it matters, and how employers can prepare as new rules roll out.
Mental Health Access: Bridging the Gap Between Awareness and Action
Mental health awareness has improved, but many employees still struggle to access timely care. Learn how smarter benefits design can bridge the gap between awareness and action.
Predictive Analytics in Benefits: What’s Real vs. Hype?
For years, the promise of predictive analytics in employee benefits has sounded almost magical: algorithms that can foresee which conditions will develop, pinpoint looming cost spikes, and deliver tailor-made strategies that optimize both spend and employee health...